Open Access Open Access  Restricted Access Subscription or Fee Access

Neurobehavioral Disorders: Mapping Biomarkers for Preclusion

Neelam Balekar


Neurobehavioral disorders include Attention Deficit Hyperactivity Disorder (ADHD), Autism Spectrum Disorder (ASD), Schizophrenia, Obsessive Compulsive Disorder (OCD)and Intellectual Disability (ID) as present serious problems for individuals as well as the community. These illnesses are characterized by a wide range of complex symptoms, which makes early assessment, diagnosis, and treatment challenging. However, recent developments in technology and neuroscience have given rise to fresh understandings of the fundamental processes and potential biomarkers connected to these diseases. Recently, novel approaches and protocols have been introduced for the assessment and management of neurobehavioral disorders. Additionally, Prevention strategies that attempt to lower the incidence and degree of severity of neurobehavioral disorders are receiving more and more attention. This review article's objective is to examine the state of our comprehension of biomarkers for neurobehavioral disorders, as well as their implications for treatment and prevention strategies.


Neurobehavioral disorder biomarkers, Diagnosis, Treatment, Prevention Strategies, illness

Full Text:




What to Know About Neurobehavioral Disorders. Verywell Mind 2021.

Norwood | May Center School for Brain Injury and Neurobehavioral Disorders [Internet]. Norwood

| May Center School for Brain Injury and Neurobehavioral Disorders. Available from:


Zasler ND, Martelli MF, Jacobs HE. Neurobehavioral disorders. Handb Clin Neurol. 2013;


Volkow ND, Koob G, Baler R. Biomarkers in substance use disorders. ACS Chem Neurosci. 2015;


Ewen JB, Levin AR. Neurobehavioral Biomarkers: An EEG Family Reunion. J Clin Neurophysiol.

; 39(2):129-134.

Simone M, De Giacomo A, Palumbi R, Palazzo C, Lucisano G, Pompamea F, Micella S, Pascali M,

Gabellone A, Marzulli L, Giordano P, Gargano CD, Margari L, Frigeri A, Ruggieri M. Serum

Neurofilament Light Chain and Glial Fibrillary Acidic Protein as Potential Diagnostic Biomarkers

in Autism Spectrum Disorders: A Preliminary Study. Int J Mol Sci. 2023; 24(3):3057.

Tremblay MW, Jiang YH. DNA Methylation and Susceptibility to Autism Spectrum Disorder. Annu

Rev Med. 2019 Jan 27; 70:151-166.

Nisar S, Haris M. Neuroimaging genetics approaches to identify new biomarkers for the early

diagnosis of autism spectrum disorder. Mol Psychiatry. 2023; 17:1-4.

LaSalle JM. Epigenomic signatures reveal mechanistic clues and predictive markers for autism

spectrum disorder. Mol Psychiatry. 2023; 17:1-2.

Takahashi N, Ishizuka K, Inada T. Peripheral biomarkers of attention-deficit hyperactivity disorder:

Current status and future perspective. J Psychiatr Res. 2021; 137:465-470.

Chen H, Yang Y, Odisho D, Wu S, Yi C, Oliver BG. Can biomarkers be used to diagnose attention

deficit hyperactivity disorder? Front Psychiatry. 2023; 14:1026616.

Cecil CAM, Nigg JT. Epigenetics and ADHD: Reflections on Current Knowledge, Research

Priorities and Translational Potential. Mol Diagn Ther. 2022 Nov;26(6):581-606.

Tang Y, Gui H, Tarbox-Berry S, Hu S, Ma X, Wang Q. Genetic Mechanisms of Biomarkers in

Schizophrenia, Bipolar Disorder and Depression. Front Psychiatry. 2021; 12:736055.

Galderisi S, DeLisi LE, Borgwardt S, editors. Neuroimaging of schizophrenia and other primary

psychotic disorders: achievements and perspectives.

Galińska-Skok B, Waszkiewicz N. Markers of Schizophrenia-A Critical Narrative Update. J Clin

Med. 2022; 11(14):3964.

Dinakaran D, Sreeraj VS, Venkatasubramanian G. Biological Markers for Outcome and Recovery

in Schizophrenia. Schizophrenia Treatment Outcomes: An Evidence-Based Approach to Recovery.

; 85-9.

Fullana MA, Abramovitch A, Via E, et al. Diagnostic biomarkers for obsessive-compulsive

disorder: A reasonable quest or ignis fatuus? Neurosci Biobehav Rev. 2020; 118:504-513.

Bruin WB, Taylor L, Thomas RM, et al. Structural neuroimaging biomarkers for obsessive-

compulsive disorder in the ENIGMA-OCD consortium: medication matters. Transl Psychiatry.

; 10(1):342.

Research & Reviews: A Journal of Neuroscience

Volume 13, Issue 2

ISSN: 2277-6427 (Online), ISSN: 2348-7925 (Print)

© STM Journals 2023. All Rights Reserved 23

Herzog SA, and Brakoulias V. The Role of Neurophysiological Biomarkers in Obsessive-

Compulsive Disorder. Curr Med Chem. 2022; 29(35):5584-5594.

Alghadir AH, Gabr SA. Physical activity impact on motor development and oxidative stress

biomarkers in school children with intellectual disability. Rev Assoc Med Bras (1992). 2020;


Sengupta A, Das U, Manna K, et al. An association study of severity of intellectual disability with

peripheral biomarkers of disabled children in a rehabilitation home, Kolkata, India. Sci Rep. 2019;


Ewen JB, Potter WZ, Sweeney JA. Biomarkers and neurobehavioral diagnosis. Biomark

Neuropsychiatry. 2021 Jun; 4:100029.

Dunckley T, Coon KD, Stephan DA. Discovery and development of biomarkers of neurological

disease. Drug Discov Today. 2005; 10(5):326-34.

Quatieri TF, Williamson JR, Lambert AC. Non-invasive Biomarkers of Neurobehavioral

Performance. Lincoln Lab J. 2020; 24(1):28-59.

Kong X, Liu J, Cetinbas M, et al. New and preliminary evidence on altered oral and gut microbiota

in individuals with autism spectrum disorder (ASD): implications for ASD diagnosis and subtyping

based on microbial biomarkers. Nutrients. 2019; 11(9):2128.

Mazón-Cabrera R, Liesenborgs J, Brône B, et al. Novel maternal autoantibodies in autism spectrum

disorder: Implications for screening and diagnosis. Front Neurosci. 2023 Feb 2; 17:1067833.

Stoccoro A, Conti E, Scaffei E, Calderoni S, et al. DNA Methylation Biomarkers for Young

Children with Idiopathic Autism Spectrum Disorder: A Systematic Review. Int J Mol Sci. 2023 May


Beversdorf DQ, Anagnostou E, Hardan A, Wang P, Erickson CA, Frazier TW, Veenstra-Vander.

Precision medicine approaches for heterogeneous conditions such as autism spectrum disorders

(The need for a biomarker exploration phase in clinical trials-Phase 2m). Frontiers in Psychiatry.

; 13:1079006.

Dargenio VN, Dargenio C, Castellaneta S, et al. Intestinal Barrier Dysfunction and Microbiota-Gut-

Brain Axis: Possible Implications in the Pathogenesis and Treatment of Autism Spectrum Disorder.

Nutrients. 2023; 15(7):1620.

Arpawong TE, Klopack ET, Kim JK, et al. ADHD genetic burden associates with older epigenetic

age: mediating roles of education, behavioral and sociodemographic factors among older adults.

Clin Epigenetics. 2023; 15(1):67.

Grossman S and Berger I. Inclusion of a Computerized Test in ADHD Diagnosis Process can

Improve Trust in the Specialists' Decision and Elevate Compliance Levels. 2023, PREPRINT

(Version 1) available at Research Square []

Cao M, Martin E, Li X. Machine learning in attention-deficit/hyperactivity disorder: new

approaches toward understanding the neural mechanisms. Transl Psychiatry. 2023; 13(1):236.

Wang Y, Fang X, Wang G, et al. The association between inflammation and kynurenine pathway

metabolites in electroconvulsive therapy for schizophrenia: Implications for clinical efficacy. Brain

Behav Immun. 2023; 113:1-11.

Amer, M, Amer, R, Ahmed H, Antiphospholipid antibodies as biomarkers for schizophrenia. Int J

Res Psychiatry. 2023; 3(1):01-08.

Zhang HC, Du Y, Chen L, etal. MicroRNA schizophrenia: Etiology, biomarkers and therapeutic

targets. Neurosci Biobehav Rev. 2023; 146:105064.

Carmeli E, Imam B, Bachar A, Merrick J. Inflammation and oxidative stress as biomarkers of

premature aging in persons with intellectual disability. Res Dev Disabil. 2012; 33(2):369-75.

McManus BM and Nugent JK. A neurobehavioral intervention incorporated into a state early

intervention program is associated with higher perceived quality of care among parents of high-risk

newborns. J Behav Health Serv Res. 2014; 41(3):381-9.

Camerota M, McGowan EC, Carter BS, et al. Maternal Prenatal Risk Phenotypes and

Neurobehavioral Outcomes among Infants Born Very Preterm. The J Ped. 2023; 260:113521.

Neurobehavioral Disorders: Mapping Biomarkers for Preclusion Balekar et al.

© STM Journals 2023. All Rights Reserved 24

Wang CP, Tian Y. Effects of Maternal Environmental Exposure on Early Life Growth and

Development. In Utero Ped: Res & P 2023; 17:29-48.

Shang M, Tang M, Xue Y. Neurodevelopmental toxicity induced by airborne particulate matter. J

Appl Toxicol. 2023; 43(1):167-185.

Spittle A and Treyvaud K. The role of early developmental intervention to influence

neurobehavioral outcomes of children born preterm. Semin Perinatol. 2016; 40(8):542-548.

Cai Y, Liu P, Zhou X, et al. Probiotics therapy show significant improvement in obesity and

neurobehavioral disorders symptoms. Front Cell Infect Microbiol. 2023; 13:1178399.

Hu Y, Xing B, Wang H, et al. Screen Time and Children: The Relationship between Preschool

Children’s Household Screen Media Experience and Executive Functioning. Open J So Sci. 2023

Jun 7; 11(6):470-85.

Skalidou S, Anestis A, Bakolas N, et al. Swimming Activity Alleviates the Symptoms of Attention:

Deficit Hyperactivity Disorder (ADHD) A Case Report. In Healthcare 2023; 11(14):1999.

Singh S. Chess and the human brain-Demystifying the therapeutic value of a board game. J High

School Sci. 2023; 7(3).

Kip E and Parr-Brownlie LC. Healthy lifestyles and wellbeing reduce neuroinflammation and

prevent neurodegenerative and psychiatric disorders. Front Neuro. 2023; 17:1092537.

Curtis K, Weinrib A, Katz J. Systematic review of yoga for pregnant women: current status and

future directions. Evid Based Complement Alternat Med. 2012; 2012:715942.



  • There are currently no refbacks.

Copyright (c) 2023 Research & Reviews: Journal of Neuroscience